Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis (JIA) patients

被引：0
|
作者：
South-Wood, Taunton [1 ]
Cummins, Carole [1 ]
Cotter, Catherine [1 ]
Rahman, Joy [1 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S943 / S944
页数：2
相关论文
共 50 条
  • [41] Psoriasis after treatment of juvenile idiopathic arthritis with etanercept
    Peek, R.
    Scott-Jupp, R.
    Strike, H.
    Clinch, J.
    Ramanan, A. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) : 1259 - 1259
  • [42] Etanercept treatment in juvenile idiopathic arthritis: The Polish registry
    Zuber, Zbigniew
    Rutkowska-Sak, Lidia
    Postepski, Jacek
    Dobrzyniecka, Bogna
    Opoka-Winiarska, Violetta
    Kobusinska, Katarzyna
    Gietka, Piotr
    Osinska, Violetta
    Turowska-Heydel, Dorota
    Szczygielska, Izabela
    Kolodziejczyk, Beata
    Swiatek-Baczkowska, Anna
    Gazda, Agnieszka
    Wiland, Piotr
    Tlustochowicz, Witold
    Tuszkiewicz-Misztal, Ewa
    MEDICAL SCIENCE MONITOR, 2011, 17 (12): : SR35 - SR42
  • [43] Treatment prescribing patterns in a cohort of patients with juvenile idiopathic arthritis (JIA): Data from the childhood arthritis prospective study (CAPS)
    Davies R.
    Carrasco R.
    Foster H.E.
    Baildam E.
    Chieng A.
    Davidson J.E.
    Ioannou Y.
    Wedderburn L.
    Thomson W.
    Hyrich K.
    Childhood Arthritis Prospective Study
    Pediatric Rheumatology, 12 (Suppl 1)
  • [44] Effectiveness and compatibility of etanercept and methotrexate or etanercept for patients with juvenile idiopathic arthritis
    De Bock, F.
    Foeldvari, I.
    Girschick, H. J.
    Kuester, R.
    Michels, H.
    Moebius, D.
    Schmeling, H.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (07): : 628 - 629
  • [45] Enthesitis in Juvenile Idiopathic Arthritis (JIA)
    Rumsey, Dax G.
    Guzman, Jaime
    Rosenberg, Alan
    Huber, Adam
    Scuccimarri, Rosie
    Eurich, Dean
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [46] FIRST DIAGNOSIS OF UVEITIS IS NOT HIGHER AMONG JUVENILE IDIOPATHIC ARTHRITIS (JIA) PATIENTS RECEIVING ETANERCEPT COMPARED TO METHOTREXATE
    Davies, R.
    De Cock, D.
    Kearsley-Fleet, L.
    Ramanan, A.
    Hyrich, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 221 - 222
  • [47] PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
    R Nicolai
    E Cortis
    L Ravà
    C Bracaglia
    M Pardeo
    A Insalaco
    PS Buonuomo
    F De Benedetti
    AE Tozzi
    Pediatric Rheumatology, 11 (Suppl 2)
  • [48] Drug-survival and reasons for discontination of etanercept therapy in juvenile idiopathic arthritis
    Horneff, G
    Schmeling, H
    Foeldvari, I
    Ganser, G
    Girschick, HJ
    Hosbach, T
    Huppertz, H
    Keitzer, R
    Kuester, RM
    Michels, H
    Moebius, D
    Rogalski, B
    Thon, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 383 - 384
  • [49] Effectiveness of intensive rehabilitation treatment in juvenile idiopathic arthritis (JIA)
    Trevisi, E
    Facchin, D
    Battaglia, M
    Zulian, F
    Martinuzzi, A
    PROCEEDINGS OF THE 2ND WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE - ISPRM, 2003, : 305 - 308
  • [50] JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN ADOLESCENTS: A REVOLUTION IN TREATMENT BY AYURVEDA
    Saxena, Varsha
    Srivastava, Niraj
    Kumar, Amit
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (12): : 5318 - 5326
12345